AC
DXCM icon

Allstate Corporation’s DexCom DXCM Stock Holding History

Allstate Corporation’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.74M Sell
40,704
-12,088
-23% -$805K 0.03% 366
2026
Q1 		$3.32M Buy
52,792
+23,830
+82% +$1.66M 0.04% 338
2025
Q4 		$1.92M Buy
28,962
+14,639
+102% +$946K 0.03% 373
2025
Q3 		$964K Buy
+14,323
New +$1.13M 0.02% 364
2025
Q2 		– Sell
-15,631
Closed -$1.07M – 285
2025
Q1 		$1.07M Buy
15,631
+3,781
+32% +$309K 0.03% 330
2024
Q4 		$922K Buy
+11,850
New +$877K 0.03% 336
2023
Q1 		– Sell
-16,863
Closed -$1.91M – 313
2022
Q4 		$1.91M Buy
16,863
+371
+2% +$40.7K 0.06% 200
2022
Q3 		$1.33M Sell
16,492
-3,920
-19% -$332K 0.04% 263
2022
Q2 		$1.52M Buy
20,412
+10,116
+98% +$923K 0.05% 230
2022
Q1 		$1.32M Buy
10,296
+784
+8% +$85.8K 0.04% 342
2021
Q4 		$1.28M Buy
9,512
+80
+0.8% +$11.5K 0.02% 485
2021
Q3 		$1.29M Sell
9,432
-968
-9% -$122K 0.05% 225
2021
Q2 		$1.11M Buy
10,400
+1,104
+12% +$106K 0.04% 280
2021
Q1 		$835K Buy
9,296
+924
+11% +$86.7K 0.03% 365
2020
Q4 		$774K Sell
8,372
-1,452
-15% -$130K 0.02% 335
2020
Q3 		$1.01M Sell
9,824
-1,032
-10% -$108K 0.03% 237
2020
Q2 		$1.1M Sell
10,856
-144
-1% -$12.9K 0.04% 230
2020
Q1 		$740K Sell
11,000
-17,676
-62% -$1.1M 0.03% 273
2019
Q4 		$1.57M Buy
28,676
+612
+2% +$29K 0.03% 353
2019
Q3 		$1.05M Buy
28,064
+22,516
+406% +$875K 0.02% 382
2019
Q2 		$208K Sell
5,548
-2,760
-33% -$86.8K ﹤0.01% 473
2019
Q1 		$247K Buy
+8,308
New +$292K 0.01% 393

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Allstate Corporation's DXCM Position: Q2 2026 in Review

Allstate Corporation reduced its DexCom (DXCM) stake by 23% in Q2 2026, selling an estimated $805K and leaving 40,704 shares worth $2.74M. The position accounts for 0.03% of the portfolio, ranked #366.

Allstate Corporation first reported a position in DXCM in Q1 2019 and has held it in 22 quarters since. The position peaked at $3.32M in Q1 2026. 974 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Allstate Corporation held 40,704 shares of DexCom worth $2.74M as of Q2 2026.
  • Allstate Corporation sold 12,088 DexCom shares in Q2 2026, an estimated $805K.
  • DexCom made up 0.03% of Allstate Corporation's portfolio in Q2 2026, its #366 holding.
  • Allstate Corporation first reported a position in DexCom in Q1 2019 and has held it in 22 quarters since.
  • Allstate Corporation's DexCom position peaked at $3.32M in Q1 2026.
  • 974 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.